πŸ‡ΊπŸ‡Έ FDA
Patent

US 10653689

Combination-based treatment method

granted A61KA61K31/4745A61K31/5025

Quick answer

US patent 10653689 (Combination-based treatment method) held by Nektar Therapeutics expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4745, A61K31/5025, A61K31/55, A61K45/06